Tarver Michelle E

Hays Ron D, Tarver Michelle E, Eydelman Malvina, Spaeth George L, Parke David W, Singh Kuldev et al.

Researchers developed and validated the Glaucoma Outcomes Survey (GOS) to measure patient quality of life after MIGS. The GOS proved reliable, showing improved scores correlated with better visual acuity, making it a valuable tool for assessing MIGS outcomes.

Singh Kuldev, Spaeth George L, Hays Ron D, Parke David W, Tarver Michelle E, Eydelman Malvina

Cui Qi N, Hays Ron D, Tarver Michelle E, Spaeth George L, Paz Sylvia H, Weidmer Beverly et al.

Researchers developed a new patient-reported survey (Glaucoma Outcomes Survey) to assess health-related quality of life in glaucoma patients considering MIGS. This tool will help understand MIGS's impact on patients' vision-targeted well-being.

Li Tianjing, Le Jimmy T, Hays Ronald D, Cui Qi N, Eydelman Malvina, Spaeth George et al.

This study developed a patient questionnaire and found that for MIGS, patients prioritize adequate IOP control and maintaining daytime driving ability, highlighting the need for patient-centered research.

Musch David C, Tarver Michelle E, Goren Matt J, Janz Nancy K

This study developed an 18-item glaucoma symptom questionnaire (SHPC-18) that reliably measures patient-reported symptoms, correlates with disease severity, and is useful for clinical and research applications.

Le Jimmy T, Viswanathan Shilpa, Tarver Michelle E, Eydelman Malvina, Li Tianjing

MIGS device studies rarely include patient-centric outcomes like quality of life or medication burden, focusing instead on IOP reduction. This limits understanding of patient-valued benefits and risks.

Caprioli Joseph, Kim Julie H, Friedman David S, Kiang Tina, Moster Marlene R, Parrish Richard K et al.